News & Updates
Filter by Specialty:

How safe is sacubitril-valsartan plus spironolactone for ADHF?
Initiation of sacubitril-valsartan with spironolactone during hospitalization for acute decompensated heart failure (ADHF) does not result in more adverse drug reactions (ADRs), reports a study. However, patients on this regimen tend to develop hyperkalemia.
How safe is sacubitril-valsartan plus spironolactone for ADHF?
04 Jan 2025
Cuffless device may revolutionize hypertension management
A retrospective analysis shows that continual cuffless blood pressure (BP) monitoring may facilitate rapid and practical assessment of systolic BP (SBP) time-in-target range (TTR), an emerging metric of hypertension control.
Cuffless device may revolutionize hypertension management
02 Jan 2025
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.